<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04067466</url>
  </required_header>
  <id_info>
    <org_study_id>VEGYDOWN-15 (B)</org_study_id>
    <nct_id>NCT04067466</nct_id>
  </id_info>
  <brief_title>Appetite Satisfaction and Short-term Satiety of Different Plant Compositions in the Adolescent Age Group</brief_title>
  <official_title>Effect on Appetite Satisfaction and Short-term Satiety of Different Plant Compositions in the Adolescent Age Group</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratorios Ordesa</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratorios Ordesa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the satiating effect of two types of food supplements made from various
      types of fibres in the subsequent intake of other foods, in satiety, and in the regulation of
      hormones
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study assessing the effect on appetite satisfaction and short-term satiety of different
      plant compositions in the adolescent age segment wants to assess the satiating effect of two
      types of food supplements made with various types of fibers (inulin, maltodextrins, guar gum
      and dehydrated plums) in the subsequent intake of other foods, in satiety, and in the
      regulation of hormones (ghrelin, leptin and insulin) and other peptides involved in the
      mechanisms of satiety
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 26, 2017</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of satiety using objective methods (blood analysis)</measure>
    <time_frame>Change from week 1 to week 2</time_frame>
    <description>Biochemistry : glucose, urea, BUN, creatinin (all in mg/dL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of satiety (blood analysis)</measure>
    <time_frame>Change from week 1 to week 2</time_frame>
    <description>Biochemistry : GOT and GPT (UI/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of satiety using a subjective method (visual analogue scale)</measure>
    <time_frame>Change from week 1 to week 2</time_frame>
    <description>The perceived feeling of satiety will be measured using the 100mm &quot;Visual Analogue Scale&quot; labeled at a far end with a &quot;mark&quot; to the left of &quot;extremely hungry&quot;, and on the other with an &quot;extremely satiated&quot;.&quot;</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Satiety</condition>
  <condition>Appetite</condition>
  <arm_group>
    <arm_group_label>Fiber product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fiber product: Inulin, maltodextrin, gum guar, plum powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control product</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maltodextrin, plum powder</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fiber product</intervention_name>
    <description>Fiber product with inulin, maltodextrin, gum guar and plum powder.</description>
    <arm_group_label>Fiber product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control product</intervention_name>
    <description>Placebo product with maltodextrin and plum powder</description>
    <arm_group_label>Control product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women between 15 and 30 years old.

          -  Subjects with IMC&lt;25 kg/m2

          -  Subjects who have a habit of having breakfast, lunch and dinner every day

          -  Subjects who are willing to comply with the study procedures

        Exclusion Criteria:

          -  Subjects taht are taking any medicines that affect the appetite or food intake

          -  Presence of endocrine-metabolic diseases

          -  Eating disorders

          -  Subjects who are following a special diet

          -  Subjects who have changed their body weight by more than 10% in the last three months
             prior to the study

          -  Subjects who follow a restrictive dietary pattern such as vegetarians, gluten-free
             diets, weight loss diets, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis Moreno Aznar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Zaragoza</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GENUD Research Group, Universidad de Zaragoza</name>
      <address>
        <city>Zaragoza</city>
        <state>Arag√≥n</state>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 19, 2019</study_first_submitted>
  <study_first_submitted_qc>August 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2019</study_first_posted>
  <last_update_submitted>August 22, 2019</last_update_submitted>
  <last_update_submitted_qc>August 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

